DNA VACCINES

Yıl 2001, Cilt: 14 Sayı: 3, 192 - 195, 03.12.2016

Burak Aksu

Öz

Traditionally, protection against infectious diseases has relied on the use of attenuated or killed vaccines. However, many such vaccines are inadequate for reason of efficacy, safety, and cost effectiveness. Live-attenuated vaccines may be immunosuppressive, cause disease if not attenuated sufficiently, or provide limited immunity if too much attenuated. A major concern regarding the use of live vaccines is the possibility of outgrowth of more virulent organisms. Killed vaccines are often unable to generate protective levels of immunity for reasons of Ag load and loss of important epitopes during inactivation. In addition, they are frequently inconvenient, given that repeated immunization is often necessary to achieve effective levels of immunity. Further, because killed viral vaccines do not provide endogenously synthesized proteins, they are in general unable to induce cytotoxic T cells, possibly a required component of a truly effective vaccine. Subunit vaccines are generally safe but costly and poorly immunogenic. Live recombinant vaccine vectors are effective, but their repeated use in the same host may be limited by vector immunity; furthermore, they are subject to reversion events and can cause disease or death in immunocompromised hosts. There is a need for better vaccines, and recently DNA vaccines have been developed (1).

Kaynakça

• Lai WC, Pakes SF, Fen R, Lu YS, Bennett M. Therapeutic effect of DPI A immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis. J Immun 1997; 158:25 13-2516.
• Gardner MJ, Doolan DL, Hedstrom RC, et al. DHA vaccines against Malaria: immunogenicity and protection in a rodent model. J Fharm Sci 1996:85(12): 1294-1300.
• Ulmer JB, Sadoff JC, Liu MA. DPI A vaccines.
• Curr Op Immun 1996;8:531-536.
• Ulmer JB, Donnelly JJ, Barker SE, et al. Heterologous protection against Influenza by
• injection of DHA encoding a viral protein. Science 1993:259:1745-1749.
• Robinson HL, Boyle CA, Feltquate DM, et at. DHA immunization for Influenza virus: Studies using hemagglutinin and nuucleoprotein expressing DHAs. J Infect Dis 1997,176 (suppl l):s.50-55
• Tang D, DeVit M, Johnston 5/4. Genetic immunization is a simple method for eliciting an immune response. Hature 1992:356:152- 154
• Manickan E, Rouse RJ, Yu Z, et al. Genetic immunization against Herpes Simplex Virus. J Immun, 1995; 155:259-265
• Irvine RR, Rao JB, Rosenberg SA, Restifo HP. Cytokine enhancement of DHA immunization leads to effective treatment of established pulmonary métastasés. J Immun 1996:156:238-245